Pfizer Inc. (ETR:PFE)

Pfizer Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	63,833	63,627	59,554	101,175	81,288	41,651
Revenue Growth (YoY)	13.53%	6.84%	-41.14%	24.46%	95.17%	1.82%
Cost of Revenue	16,712	16,420	17,789	34,097	30,686	8,385
Gross Profit	47,121	47,207	41,765	67,078	50,602	33,266
Selling, General & Admin	14,005	14,771	13,836	12,200	9,562	11,418
Research & Development	10,289	10,822	10,679	11,428	10,360	8,709
Amortization of Goodwill & Intangibles	5,092	5,286	4,733	3,609	3,700	3,348
Operating Expenses	29,386	30,879	29,248	27,237	23,622	23,475
Operating Income	17,735	16,328	12,517	39,841	26,980	9,791
Interest Expense	-2,831	-3,091	-2,209	-1,238	-1,291	-1,449
Interest & Investment Income	833	817	2,100	565	202	351
Earnings From Equity Investments	150	102	505	436	471	298
Currency Exchange Gain (Loss)	50	50	164	-	-	-
Other Non Operating Income (Expenses)	-241	-188	217	621	1,904	1,639
EBT Excluding Unusual Items	15,696	14,018	13,294	40,225	28,266	10,630
Merger & Restructuring Charges	-2,923	-4,039	-3,999	-2,225	-1,452	-895
Gain (Loss) on Sale of Investments	1,705	1,833	1,590	-1,273	1,344	557
Gain (Loss) on Sale of Assets	420	420	222	-	-	-237
Asset Writedown	-3,263	-3,295	-3,024	-421	-86	-1,691
Legal Settlements	-754	-567	-474	-230	-182	-28
Other Unusual Items	-235	-239	-6,357	-394	-111	-616
Pretax Income	10,533	8,023	1,058	34,729	24,310	7,036
Income Tax Expense	-235	-28	-1,115	3,328	1,852	370
Earnings From Continuing Operations	10,768	8,051	2,173	31,401	22,458	6,666
Earnings From Discontinued Operations	24	11	-15	6	-434	2,529
Net Income to Company	10,792	8,062	2,158	31,407	22,024	9,195
Minority Interest in Earnings	-40	-31	-39	-35	-45	-36
Net Income	10,752	8,031	2,119	31,372	21,979	9,159
Net Income to Common	10,752	8,031	2,119	31,372	21,979	9,159
Net Income Growth	-	279.00%	-93.25%	42.74%	139.97%	-42.85%
Shares Outstanding (Basic)	5,673	5,664	5,643	5,608	5,601	5,555
Shares Outstanding (Diluted)	5,706	5,700	5,709	5,733	5,708	5,632
Shares Change (YoY)	0.92%	-0.16%	-0.42%	0.44%	1.35%	-0.76%
EPS (Basic)	1.90	1.42	0.38	5.59	3.92	1.65
EPS (Diluted)	1.89	1.41	0.37	5.47	3.85	1.63
EPS Growth	-	284.33%	-93.28%	41.96%	136.58%	-42.31%
Free Cash Flow	12,438	9,835	4,793	26,031	29,869	12,177
Free Cash Flow Per Share	2.18	1.73	0.84	4.54	5.23	2.16
Dividend Per Share	1.700	1.680	1.640	1.600	1.560	1.520
Dividend Growth	2.41%	2.44%	2.50%	2.56%	2.63%	5.56%
Gross Margin	73.82%	74.19%	70.13%	66.30%	62.25%	79.87%
Operating Margin	27.78%	25.66%	21.02%	39.38%	33.19%	23.51%
Profit Margin	16.84%	12.62%	3.56%	31.01%	27.04%	21.99%
Free Cash Flow Margin	19.48%	15.46%	8.05%	25.73%	36.74%	29.24%
EBITDA	24,506	23,322	18,775	44,869	32,084	14,455
EBITDA Margin	38.39%	36.65%	31.53%	44.35%	39.47%	34.71%
D&A For EBITDA	6,771	6,994	6,258	5,028	5,104	4,664
EBIT	17,735	16,328	12,517	39,841	26,980	9,791
EBIT Margin	27.78%	25.66%	21.02%	39.38%	33.19%	23.51%
Effective Tax Rate	-	-	-	9.58%	7.62%	5.26%
Revenue as Reported	63,832	63,627	59,553	101,175	81,288	-
Advertising Expenses	-	3,300	3,700	2,800	2,000	1,800

Source: S&P Global Market Intelligence. Standard template. Financial Sources.